Sustainability & Climate

The energy giant's dividend increase to $1.27 reflects robust financial health, strategic pivots to renewables, and a strong commitment to shareholders.

The rail giant's acquisition of the Swedish coupler leader signals a major strategic push into the global passenger transit market. Here's what it means.

A 'world-first' cervical implant from Zavation Medical Products combines two materials to enhance bone growth while maintaining critical imaging capabilities.

As Valentine's and Family Day approach, MADD Canada's new campaign confronts a rise in risky behaviour and a decline in public concern over impaired driving.

A non-invasive device for spinal cord injury gains major international praise, signaling a shift in neurorehabilitation and a path to market.

Australian biotech Amplia Therapeutics is bringing its promising pancreatic cancer trial to the US, a key step in developing a drug that targets the disease's defenses.

As North Carolina's population booms, a new partnership aims to expand access to cutting-edge fertility care, research, and education across the state.

After a decade-long battle with Stage 4 cancer, one patient's cure spotlights a revolutionary immunotherapy and its potential to change cancer treatment.

OTR Solutions acquires AI firm Peruse, signaling a major move to dominate logistics fintech with specialized AI for document automation and fraud prevention.

Supply chain giant Li & Fung signs a major licensing deal to expand the iconic C&C California brand into swim, sleepwear, and outerwear categories.

For the seventh year, General Mills is one of America's most responsible companies. We explore the data, public trust, and strategy behind this major ESG achievement.

Radiation tech giant Mirion appoints three new executives, signaling a major strategic push into next-gen nuclear, advanced cancer care, and AI.

Following key FDA progress for its oral osteoporosis drug, Entera Bio's CEO and board members are buying up company stock, signaling deep confidence.

Katherine Stueland’s honor underscores a major shift in healthcare, as genomic screening and AI promise to end the diagnostic odyssey for rare diseases.

UCLA's Dr. Donald Kohn joins the Jeffrey Modell Foundation to discuss revolutionary gene therapies offering new hope for Primary Immunodeficiency patients.

BrightNight's massive solar and battery project in Yuma County promises reliable power, hundreds of jobs, and millions for Arizona's schools.

From Millennial micro-cruises to Boomer bucket lists, a new report reveals the deep generational divides reshaping the future of travel and tourism.

Rapid7's 2026 awards reveal a shift in cybersecurity, where partners are no longer just resellers but crucial allies in the global, AI-driven fight.

A new partnership with Uniphar will use managed access programs to provide the lymphoma therapy LYMPHIR to European patients with limited treatment options.

A strategic franchise acquisition in Fairfield County aims to serve Connecticut's rapidly aging population, ensuring continuity of care for local seniors.